FDA approves human trials for Musk's neuralink brain implant

California: Elon Musk's Neuralink brain implant has received FDA approval for human trials, marking a significant milestone in the development of this groundbreaking technology.

The coin-sized device, which is implanted in the skull using ultra-thin wires connected directly to the brain, aims to revolutionize medical interventions and potentially transcend the limits of human abilities.

The initial focus of the human trials will be on restoring vision and assisting individuals with limited muscle control in operating digital devices.

However, the potential applications of the Neuralink implant go beyond medical purposes.

Elon Musk envisions a future where the technology can create a new kind of hybrid beings—part-human, part-robot cyborgs—capable of surpassing the capabilities of able-bodied humans.

Remarkable results have already been demonstrated during testing.

A monkey with the Neuralink implant achieved impressive control, reaching 65% and 88% of the median Neuralinker's precision cursor control using a mouse.

This progress fuels the belief that full-body functionality can be restored to individuals with severed spinal cords, pushing the boundaries of what was once deemed impossible.